High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

Trial Profile

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2015

At a glance

  • Drugs Lurasidone (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Sep 2014 Planned primary completion date changed from 1 Dec 2014 to 1 May 2015 as reported by ClinicalTrial.gov.
    • 18 Feb 2014 Planned End Date changed from 1 Apr 2014 to 1 Dec 2014 as reported by ClinicalTrial.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top